We are live on ! Find out more
HPTX

HYPERION THERAPEUTICS INC COM STK (DE)
HPTX

Delisted

HPTX was delisted on the 7th of May, 2015.

61 hedge funds and large institutions have $295M invested in HYPERION THERAPEUTICS INC COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 17

0% more funds holding

Funds holding: 6161 (0)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

17% less capital invested

Capital invested by funds: $353M → $295M (-$58.8M)

Holders
61
Holders Change
Holders Change %
0%
% of All Funds
1.77%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
12
Increased
23
Reduced
17
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Macquarie Group
26
Macquarie Group
Australia
$701K +$283K +12,036 +53%
TCIM
27
TIAA CREF Investment Management
New York
$698K
Geode Capital Management
28
Geode Capital Management
Massachusetts
$674K +$48.3K +2,053 +7%
Ameriprise
29
Ameriprise
Minnesota
$648K +$578K +24,569 +329%
EAM
30
Eventide Asset Management
Massachusetts
$631K +$734K +31,200 New
Citadel Advisors
31
Citadel Advisors
Florida
$534K +$621K +26,401 New
NFA
32
Nationwide Fund Advisors
Ohio
$530K -$3.15K -134 -0.5%
Jane Street
33
Jane Street
New York
$502K +$584K +24,813 New
CS
34
Credit Suisse
Switzerland
$486K +$567K +24,081 New
BIM
35
BlackRock Investment Management
Delaware
$471K -$12K -508 -2%
NTCOC
36
Northern Trust Company of Connecticut
Connecticut
$469K +$153K +6,494 +39%
GCP
37
GSA Capital Partners
United Kingdom
$414K +$224K +9,499 +86%
Charles Schwab
38
Charles Schwab
California
$399K +$11.9K +504 +3%
AQR Capital Management
39
AQR Capital Management
Connecticut
$378K +$440K +18,709 New
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$308K +$4.71K +200 +1%
TA
41
Teachers Advisors
New York
$269K +$48.7K +2,070 +18%
LMF
42
LMR Master Fund
Cayman Islands
$241K +$281K +11,918 New
DekaBank Deutsche Girozentrale
43
DekaBank Deutsche Girozentrale
Germany
$238K +$4.71K +200 +2%
MLICM
44
Metropolitan Life Insurance Company (MetLife)
New York
$149K
Bank of America
45
Bank of America
North Carolina
$138K +$108K +4,570 +202%
KBC Group
46
KBC Group
Belgium
$129K +$66.4K +2,821 +80%
AIG
47
American International Group
New York
$113K -$1.32K -56 -1%
SO
48
STRS Ohio
Ohio
$105K -$14.1K -600 -10%
Swiss National Bank
49
Swiss National Bank
Switzerland
$101K
Invesco
50
Invesco
Georgia
$101K +$117K +4,986 New

HPTX Hedge Fund Activity: Q4 2013 in Review

61 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) for Q4 2013, worth a combined $295M — down 17% from $353M a quarter earlier.

Fund positioning in HPTX was balanced in Q4 2013: 12 funds opened new positions, 12 closed out, 23 added to existing stakes and 17 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $15.3M. The largest seller was RA Capital Management, exiting entirely with an estimated $23.6M sold.

  • 61 institutional investors held HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $295M of HYPERION THERAPEUTICS INC COM STK (DE) stock for Q4 2013, down 17% quarter-over-quarter.
  • 12 funds opened new HYPERION THERAPEUTICS INC COM STK (DE) positions in Q4 2013 and 12 closed out, a net change of 0 holders.
  • The largest HYPERION THERAPEUTICS INC COM STK (DE) buyer in Q4 2013 was Consonance Capital Management, an estimated $15.3M added.
  • The largest HYPERION THERAPEUTICS INC COM STK (DE) seller in Q4 2013 was RA Capital Management, an estimated $23.6M sold.

Based on aggregated 13F filings for Q4 2013.